Skip to content

Fibromyalgia Integrative Training for Adolescents With Juvenile Fibromyalgia

Multi-site Randomized Clinical Trial of FIT Teens for Juvenile Fibromyalgia

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT03268421
Acronym
FIT Teens
Enrollment
389
Registered
2017-08-31
Start date
2018-01-02
Completion date
2023-12-21
Last updated
2025-02-14

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Fibromyalgia, Muscular Diseases, Musculoskeletal Disease, Myofascial Pain Syndrome, Rheumatic Diseases

Keywords

juvenile fibromyalgia, pain in children, musculoskeletal pain, cognitive behavioral therapy, coping skills training, neuromuscular exercise, graded aerobic exercise

Brief summary

This study evaluated whether Fibromyalgia Integrative Training program for Teens (FIT Teens), a combined cognitive behavioral therapy and neuromuscular exercise training program is more effective in reducing disability in adolescents with Juvenile Fibromyalgia compared to cognitive behavioral therapy (CBT) alone or a graded aerobic exercise (GAE) program alone. One third of participants received the FIT Teens training; one third received CBT training; and one third of participants received the GAE training.

Detailed description

Juvenile-onset fibromyalgia (JFM) is a chronic, debilitating pain condition that typically persists into adulthood for the majority of patients. Whereas medications offer limited and short-term symptom relief for JFM, our research group has demonstrated that cognitive-behavioral therapy (CBT) is safe, effective and durable in reducing functional disability and depressive symptoms in adolescents with this condition. However, 60% of patients receiving CBT did not show clinically significant improvement in functional disability, and pain levels remained in the moderate range despite being reduced overall. Our multidisciplinary team of experts in Behavioral Medicine, Rheumatology and Exercise Science has developed and tested the feasibility of a new Fibromyalgia Integrative Training program for Teens (FIT Teens), which enhances the established CBT intervention with a novel neuromuscular exercise training program derived from evidence-based pediatric injury prevention research. Pilot testing showed excellent patient engagement, no adverse effects and very promising early results indicating this treatment to have even stronger effects on disability and pain outcomes than CBT alone. This trial evaluated whether the FIT Teens intervention is more effective than CBT alone or graded aerobic exercise alone and whether treatment effects are sustainable over 1 year follow-up.

Interventions

BEHAVIORALFibromyalgia Integrative Training for Teens

This intervention will consist of 16 in-person group-based sessions held twice per week over 8 weeks. Sessions last 90 minutes and will be led jointly by a psychologist/therapist and exercise trainer using manualized protocols.

BEHAVIORALCognitive Behavioral Therapy

This intervention will consist of 16 in-person group-based sessions held twice per week over 8 weeks. Sessions last 90 minutes and will be led jointly by a psychologist/therapist and exercise trainer using manualized protocols.

This intervention will consist of 16 in-person group-based sessions held twice per week over 8 weeks. Sessions last 90 minutes and will be led jointly by a psychologist/therapist and exercise trainer using manualized protocols.

Sponsors

National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS)
CollaboratorNIH
Children's Hospital Medical Center, Cincinnati
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
DOUBLE (Investigator, Outcomes Assessor)

Intervention model description

Non-pharmacologic trial comparing behavioral and exercise-based treatments

Eligibility

Sex/Gender
ALL
Age
12 Years to 18 Years
Healthy volunteers
No

Inclusion criteria

* Juvenile Fibromyalgia diagnosis by pediatric rheumatologist or pain physician and confirmed by 2010 American College of Rheumatology (ACR) criteria modified for pediatric use * Functional Disability Score ≥ 13, indicating at least moderate disability * Average pain intensity in the past week ≥ 4 on a 0 -10 cm Visual Analog Scale * Stable medications prior to enrollment

Exclusion criteria

* Comorbid rheumatic disease (e.g. juvenile arthritis, systemic lupus erythematous) * Untreated major psychiatric diagnoses (e.g. bipolar disorder, psychoses, symptoms of major depression) or documented developmental delay * Any medical condition determined by their physician to be a contraindication for physical exercise * Taking opioid pain medication

Design outcomes

Primary

MeasureTime frameDescription
Functional Disability InventoryBaseline to 3 month follow up (primary endpoint) and 6, 9 and 12 month follow-upFunctional Disability Inventory (FDI) is a validated 15-item self-report measure, developed to assess perceived difficulty in the performance of daily activities in home, school, recreational, and social domains due to pain. Total sum scores are calculated and range from 0 - 60, with higher scores indicating greater functional disability. Clinical reference points are: No/Minimal disability (0 to 12), Mild disability (13 to 20), Moderate disability (21 to 29) and Severe disability (≥30). For this primary outcome, data from this questionnaire was used to compare baseline response to 3 month follow up to examine whether a reduction in disability occurs. The main outcome measure for this comparison is the difference in baseline and primary endpoint (3 month) FDI scores for each of the three interventions (FIT Teens, CBT, and GAE).

Secondary

MeasureTime frameDescription
Pain IntenstiyBaseline to 3 month follow up (primary endpoint) and 6, 9 and 12 month follow-upPain intensity was measured using the Visual Analog Scale (VAS), which is a validated measure of pain intensity in children and adolescents. Participants were shown a line with the written anchors of no pain and pain as bad as I can imagine on either end. The line represents a 0-10 scale, where higher scores are representative of higher pain intensity with a score of 4-6 indicating at least moderate pain levels and a score of 7-10 indicating severe pain levels. This measure was completed daily for one week and scores averaged over that time. For this secondary outcome, data from this measure were used to compare baseline response to 3 month follow up to examine whether a reduction in pain intensity occurred.

Countries

Canada, United States

Participant flow

Pre-assignment details

Due to the group-based nature of the study, potential participants completed their baseline (T1) assessment and then waited up to 4 weeks before treatment assignment. A potential participant would be excluded from the study prior to treatment assignment for the reasons of screen-fails, no longer interested in the study, starting a disallowed treatment, or are lost to contact.

Participants by arm

ArmCount
Fibromyalgia Integrative Training for Teens
Fibromyalgia Integrative Training for Teens (FIT Teens) is a combined cognitive behavioral therapy and neuromuscular training.
103
Cognitive Behavioral Therapy
Cognitive Behavioral Therapy (CBT) is a psychological pain coping skills training program.
110
Graded Aerobic Exercise
Graded aerobic exercise (GAE) is a circuit-training exercise program with short intervals of aerobic exercise interspersed with brief rest breaks.
104
Total317

Baseline characteristics

CharacteristicFibromyalgia Integrative Training for TeensTotalGraded Aerobic ExerciseCognitive Behavioral Therapy
Age, Categorical
<=18 years
103 Participants317 Participants104 Participants110 Participants
Age, Categorical
>=65 years
0 Participants0 Participants0 Participants0 Participants
Age, Categorical
Between 18 and 65 years
0 Participants0 Participants0 Participants0 Participants
Age, Continuous15.73 years
STANDARD_DEVIATION 1.49
15.76 years
STANDARD_DEVIATION 1.53
15.96 years
STANDARD_DEVIATION 1.47
15.61 years
STANDARD_DEVIATION 1.61
Ethnicity (NIH/OMB)
Hispanic or Latino
5 Participants25 Participants9 Participants11 Participants
Ethnicity (NIH/OMB)
Not Hispanic or Latino
98 Participants292 Participants95 Participants99 Participants
Ethnicity (NIH/OMB)
Unknown or Not Reported
0 Participants0 Participants0 Participants0 Participants
Functional Disability Inventory (FDI)25.73 units on a scale
STANDARD_DEVIATION 8.67
25.22 units on a scale
STANDARD_DEVIATION 5.84
25.95 units on a scale
STANDARD_DEVIATION 8.33
24.05 units on a scale
STANDARD_DEVIATION 7.95
Pain Intensity (VAS)5.71 units on a scale
STANDARD_DEVIATION 1.3
5.84 units on a scale
STANDARD_DEVIATION 1.3
5.88 units on a scale
STANDARD_DEVIATION 1.26
5.93 units on a scale
STANDARD_DEVIATION 1.34
Race (NIH/OMB)
American Indian or Alaska Native
1 Participants4 Participants0 Participants3 Participants
Race (NIH/OMB)
Asian
1 Participants5 Participants4 Participants0 Participants
Race (NIH/OMB)
Black or African American
7 Participants18 Participants4 Participants7 Participants
Race (NIH/OMB)
More than one race
8 Participants22 Participants6 Participants8 Participants
Race (NIH/OMB)
Native Hawaiian or Other Pacific Islander
1 Participants1 Participants0 Participants0 Participants
Race (NIH/OMB)
Unknown or Not Reported
0 Participants0 Participants0 Participants0 Participants
Race (NIH/OMB)
White
85 Participants267 Participants90 Participants92 Participants
Region of Enrollment
Canada
0 participants3 participants0 participants3 participants
Region of Enrollment
United States
103 participants314 participants104 participants107 participants
Sex: Female, Male
Female
98 Participants294 Participants99 Participants97 Participants
Sex: Female, Male
Male
5 Participants23 Participants5 Participants13 Participants

Adverse events

Event typeEG000
affected / at risk
EG001
affected / at risk
EG002
affected / at risk
deaths
Total, all-cause mortality
0 / 1030 / 1100 / 104
other
Total, other adverse events
12 / 10310 / 11016 / 104
serious
Total, serious adverse events
0 / 1030 / 1100 / 104

Outcome results

Primary

Functional Disability Inventory

Functional Disability Inventory (FDI) is a validated 15-item self-report measure, developed to assess perceived difficulty in the performance of daily activities in home, school, recreational, and social domains due to pain. Total sum scores are calculated and range from 0 - 60, with higher scores indicating greater functional disability. Clinical reference points are: No/Minimal disability (0 to 12), Mild disability (13 to 20), Moderate disability (21 to 29) and Severe disability (≥30). For this primary outcome, data from this questionnaire was used to compare baseline response to 3 month follow up to examine whether a reduction in disability occurs. The main outcome measure for this comparison is the difference in baseline and primary endpoint (3 month) FDI scores for each of the three interventions (FIT Teens, CBT, and GAE).

Time frame: Baseline to 3 month follow up (primary endpoint) and 6, 9 and 12 month follow-up

ArmMeasureGroupValue (MEAN)
Fibromyalgia Integrative Training for TeensFunctional Disability Inventory9-month endpoint21.56 score on a scale
Fibromyalgia Integrative Training for TeensFunctional Disability Inventory6-month endpoint21.26 score on a scale
Fibromyalgia Integrative Training for TeensFunctional Disability InventoryBaseline25.78 score on a scale
Fibromyalgia Integrative Training for TeensFunctional Disability Inventory3-month endpoint21.83 score on a scale
Fibromyalgia Integrative Training for TeensFunctional Disability Inventory12-month endpoint21.02 score on a scale
Cognitive Behavioral TherapyFunctional Disability Inventory6-month endpoint21.01 score on a scale
Cognitive Behavioral TherapyFunctional Disability InventoryBaseline24.10 score on a scale
Cognitive Behavioral TherapyFunctional Disability Inventory3-month endpoint21.65 score on a scale
Cognitive Behavioral TherapyFunctional Disability Inventory9-month endpoint20.71 score on a scale
Cognitive Behavioral TherapyFunctional Disability Inventory12-month endpoint20.15 score on a scale
Graded Aerobic ExerciseFunctional Disability Inventory12-month endpoint21.22 score on a scale
Graded Aerobic ExerciseFunctional Disability Inventory9-month endpoint23.37 score on a scale
Graded Aerobic ExerciseFunctional Disability InventoryBaseline25.96 score on a scale
Graded Aerobic ExerciseFunctional Disability Inventory6-month endpoint23.34 score on a scale
Graded Aerobic ExerciseFunctional Disability Inventory3-month endpoint24.70 score on a scale
Secondary

Pain Intenstiy

Pain intensity was measured using the Visual Analog Scale (VAS), which is a validated measure of pain intensity in children and adolescents. Participants were shown a line with the written anchors of no pain and pain as bad as I can imagine on either end. The line represents a 0-10 scale, where higher scores are representative of higher pain intensity with a score of 4-6 indicating at least moderate pain levels and a score of 7-10 indicating severe pain levels. This measure was completed daily for one week and scores averaged over that time. For this secondary outcome, data from this measure were used to compare baseline response to 3 month follow up to examine whether a reduction in pain intensity occurred.

Time frame: Baseline to 3 month follow up (primary endpoint) and 6, 9 and 12 month follow-up

ArmMeasureGroupValue (MEAN)
Fibromyalgia Integrative Training for TeensPain Intenstiy9-month endpoint5.07 units on a scale
Fibromyalgia Integrative Training for TeensPain Intenstiy6-month endpoint5.27 units on a scale
Fibromyalgia Integrative Training for TeensPain Intenstiy12-month endpoint4.91 units on a scale
Fibromyalgia Integrative Training for TeensPain Intenstiy3-month endpoint5.29 units on a scale
Fibromyalgia Integrative Training for TeensPain IntenstiyBaseline5.71 units on a scale
Cognitive Behavioral TherapyPain IntenstiyBaseline5.93 units on a scale
Cognitive Behavioral TherapyPain Intenstiy3-month endpoint5.41 units on a scale
Cognitive Behavioral TherapyPain Intenstiy6-month endpoint5.19 units on a scale
Cognitive Behavioral TherapyPain Intenstiy9-month endpoint5.13 units on a scale
Cognitive Behavioral TherapyPain Intenstiy12-month endpoint4.88 units on a scale
Graded Aerobic ExercisePain Intenstiy12-month endpoint5.18 units on a scale
Graded Aerobic ExercisePain Intenstiy9-month endpoint5.45 units on a scale
Graded Aerobic ExercisePain IntenstiyBaseline5.88 units on a scale
Graded Aerobic ExercisePain Intenstiy6-month endpoint5.42 units on a scale
Graded Aerobic ExercisePain Intenstiy3-month endpoint5.44 units on a scale

Source: ClinicalTrials.gov · Data processed: Feb 23, 2026